Elizabeth M E Verdegaal (Els M E Verdegaal, Els Verdegaal, Els Me Verdegaal)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Systematic Review

Systemic Lupus Erythematosus

Top Venues

Journal for immunotherapy of cancer

Cancer immunology research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, Theo Rispens, Elizabeth M E Verdegaal, Dirk J A R Moes, Catharina M Korse, Ellen H W Kapiteijn, Marij J P Welters, Sjoerd H Van der Burg, Winan J van Houdt, Johannes V van Thienen, John B A G Haanen, Diane van der Woude
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, Theo Rispens, Elizabeth M E Verdegaal, Dirk J A R Moes, Catharina M Korse, Ellen H W Kapiteijn, Marij J P Welters, Sjoerd H Van der Burg, Winan J van Houdt, Johannes V van Thienen, John B A G Haanen, Diane van der Woude
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing antibodies impair the oncolytic efficacy of reovirus but permit effective combination with T cell-based immunotherapies. Cancer immunology research (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, Theo Rispens, Elizabeth M E Verdegaal, Dirk J A R Moes, Catharina M Korse, Ellen H W Kapiteijn, Marij J P Welters, Sjoerd H Van der Burg, Winan J van Houdt, Johannes V van Thienen, John B A G Haanen, Diane van der Woude
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, Theo Rispens, Elizabeth M E Verdegaal, Dirk J A R Moes, Catharina M Korse, Ellen H W Kapiteijn, Marij J P Welters, Sjoerd H Van der Burg, Winan J van Houdt, Johannes V van Thienen, John B A G Haanen, Diane van der Woude
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Elizabeth M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, Noel F C C de Miranda
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden. Journal for immunotherapy of cancer 11 (2) (2023)
Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Elizabeth M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, Noel F C C de Miranda
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden. Journal for immunotherapy of cancer 11 (2) (2023)
Jitske van den Bulk, Elizabeth M E Verdegaal, Manon van der Ploeg, Marten Visser, Joana B Nunes, Arnoud H de Ru, Rayman T N Tjokrodirijo, Marieke E Ijsselsteijn, Natasja I Janssen, Ruud van der Breggen, Linda de Bruin, Pita de Kok, George M C Janssen, Dina Ruano, Ellen H W Kapiteijn, Peter A van Veelen, Noel F C C de Miranda, Sjoerd H Van der Burg
Neoantigen targetability in progressive advanced melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Elizabeth M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, Noel F C C de Miranda
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden. Journal for immunotherapy of cancer 11 (2) (2023)
Elizabeth M E Verdegaal, Saskia J A M Santegoets, Marij J P Welters, Linda de Bruin, Marten Visser, Caroline E van der Minne, Pita M de Kok, Nikki M Loof, Sanne Boekestijn, Inge Roozen, Inge M Westra, Pauline Meij, Sjoerd H Van der Burg, Judith R Kroep
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer. Journal for immunotherapy of cancer 11 (11) (2023)
Tom J Harryvan, Marten Visser, Linda de Bruin, Léonie Plug, Lisa Griffioen, Arend Mulder, Peter A van Veelen, Gerbrand J van der Heden van Noort, Marlieke Lm Jongsma, Miranda H Meeuwsen, Emmanuel Jhj Wiertz, Saskia J A M Santegoets, James Ch Hardwick, Thorbald van Hall, Jacques Neefjes, Sjoerd H Van der Burg, Lukas J A C Hawinkels, Elizabeth M E Verdegaal
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. Journal for immunotherapy of cancer 10 (3) (2022)
Tom J Harryvan, Sabine de Lange, Lukas J A C Hawinkels, Elizabeth M E Verdegaal
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells. International journal of molecular sciences 23 (1) (2021)
Joosje C Baltussen, Marij J P Welters, Elizabeth M E Verdegaal, Ellen H W Kapiteijn, Anne M R Schrader, Marije Slingerland, Gerrit-Jan Liefers, Sjoerd H Van der Burg, Johanneke E A Portielje, Nienke A de Glas
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review. Cancers 13 (24) (2021)
Elizabeth M E Verdegaal, Monique K Van der Kooij, Marten Visser, Caroline van der Minne, Linda de Bruin, Pauline Meij, Anton Terwisscha van Scheltinga, Marij J Welters, Saskia Santegoets, Noel F C C de Miranda, Inge Roozen, Gerrit Jan Liefers, Ellen Kapiteijn, Sjoerd H Van der Burg
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study. Journal for immunotherapy of cancer 8 (1) (2021)
Daniel P Hurkmans, Elizabeth M E Verdegaal, Sabrina A Hogan, Rik de Wijn, Lies Hovestad, Dianne M A van den Heuvel, Rob Ruijtenbeek, Marij J P Welters, Mandy van Brakel, Edwin A Basak, Herbert M Pinedo, Cor H J Lamers, Harmen J G van de Werken, John P Groten, Reno Debets, Mitchell Paul Levesque, Reinhard Dummer, Ellen Kapiteijn, Ron H J Mathijssen, Joachim G J V Aerts, Sjoerd H Van der Burg
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Tom J Harryvan, Elizabeth M E Verdegaal, James C H Hardwick, Lukas J A C Hawinkels, Sjoerd H Van der Burg
Targeting of the Cancer-Associated Fibroblast-T-Cell Axis in Solid Malignancies. Journal of clinical medicine 8 (11) (2019)
Koen A Marijt, Laura Blijleven, Elizabeth M E Verdegaal, Michel G Kester, Daniel J Kowalewski, Hans-Georg Rammensee, Stefan Stevanovic, Mirjam H M Heemskerk, Sjoerd H Van der Burg, Thorbald van Hall
Identification of non-mutated neoantigens presented by TAP-deficient tumors. The Journal of experimental medicine 215 (9) (2018)